China's sinovac vaccine gets accolades, Johnson & Johnson jabbing linked for 23 blood clotting case


As the global economy gradually overcomes the pandemic, except for India and Japan, Bloomberg came out with the report suggesting China’s coronavirus (COVID-19) vaccine from the Sinovac Biotech Ltd. as highly effective in the real-world study.

The report cites research on the Indonesian health workers and found over 96% got protected from hospitalization due to the jabbing. “Indonesia tracked 25,374 health workers in capital city Jakarta for 28 days after they received their second dose and found that the vaccine protected 100% of them from death and 96% from hospitalization as soon as seven days after, said Health Minister Budi Gunadi Sadikin in an interview on Tuesday. The workers were tracked until late February,” said Bloomberg.

Earlier Brazil was spotted cheering the Chinese vaccine while Chile criticized the pandemic’s cure.

Elsewhere, the US Centers for Disease Control and Prevention (CDC) found 23 blood clotting issues linked to the Johnson & Johnson inoculation while saying, “the benefits of the Johnson & Johnson vaccine outweigh the risks.”

It's worth mentioning that Brazil suspended the use of the AstraZeneca vaccine in pregnant women while Pfizer-BioNTech gets multiple orders from the Eurozone of late.

FX implications

Although the news should have ideally favored the market sentiment, the pre-US CPI caution seems to weigh on the mood.

Read: AUD/USD: Wavers above 0.7800 amid cautious sentiment on US Inflation day

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Recommended content


Recommended content

Editors’ Picks

EUR/USD holds steady near 1.0650 amid risk reset

EUR/USD holds steady near 1.0650 amid risk reset

EUR/USD is holding onto its recovery mode near 1.0650 in European trading on Friday. A recovery in risk sentiment is helping the pair, as the safe-haven US Dollar pares gains. Earlier today, reports of an Israeli strike inside Iran spooked markets. 

EUR/USD News

GBP/USD recovers toward 1.2450 after UK Retail Sales data

GBP/USD recovers toward 1.2450 after UK Retail Sales data

GBP/USD is rebounding toward 1.2450 in early Europe on Friday, having tested 1.2400 after the UK Retail Sales volumes stagnated again in March, The pair recovers in tandem with risk sentiment, as traders take account of the likely Israel's missile strikes on Iran. 

GBP/USD News

Gold price defends gains below $2,400 as geopolitical risks linger

Gold price defends gains below $2,400 as geopolitical risks linger

Gold price is trading below $2,400 in European trading on Friday, holding its retreat from a fresh five-day high of $2,418. Despite the pullback, Gold price remains on track to book the fifth weekly gain in a row, supported by lingering Middle East geopolitical risks.

Gold News

Bitcoin Weekly Forecast: BTC post-halving rally could be partially priced in Premium

Bitcoin Weekly Forecast: BTC post-halving rally could be partially priced in

Bitcoin price shows no signs of directional bias while it holds above  $60,000. The fourth BTC halving is partially priced in, according to Deutsche Bank’s research. 

Read more

Geopolitics once again take centre stage, as UK Retail Sales wither

Geopolitics once again take centre stage, as UK Retail Sales wither

Nearly a week to the day when Iran sent drones and missiles into Israel, Israel has retaliated and sent a missile into Iran. The initial reports caused a large uptick in the oil price.

Read more

Forex MAJORS

Cryptocurrencies

Signatures